ZA937453B - 1-substituted oxindoles and azaoxindoles as novel cognition enhancers - Google Patents

1-substituted oxindoles and azaoxindoles as novel cognition enhancers

Info

Publication number
ZA937453B
ZA937453B ZA937453A ZA937453A ZA937453B ZA 937453 B ZA937453 B ZA 937453B ZA 937453 A ZA937453 A ZA 937453A ZA 937453 A ZA937453 A ZA 937453A ZA 937453 B ZA937453 B ZA 937453B
Authority
ZA
South Africa
Prior art keywords
azaoxindoles
novel
cognition enhancers
substituted oxindoles
oxindoles
Prior art date
Application number
ZA937453A
Other languages
English (en)
Inventor
Christopher Allan Teleha
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of ZA937453B publication Critical patent/ZA937453B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA937453A 1992-10-07 1993-10-07 1-substituted oxindoles and azaoxindoles as novel cognition enhancers ZA937453B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/957,152 US5296478A (en) 1992-10-07 1992-10-07 1-substituted oxindoles as cognition enhancers

Publications (1)

Publication Number Publication Date
ZA937453B true ZA937453B (en) 1995-04-07

Family

ID=25499153

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937453A ZA937453B (en) 1992-10-07 1993-10-07 1-substituted oxindoles and azaoxindoles as novel cognition enhancers

Country Status (7)

Country Link
US (2) US5296478A (enExample)
AU (1) AU5292893A (enExample)
IL (1) IL107177A0 (enExample)
MX (1) MX9306234A (enExample)
TW (1) TW268943B (enExample)
WO (1) WO1994007891A1 (enExample)
ZA (1) ZA937453B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744476A (en) * 1994-06-27 1998-04-28 Interneuron Pharmaceuticals, Inc. Dopamine D1 agonists for the treatment of dementia
DK0813411T3 (da) * 1995-02-15 2002-05-13 Takeda Chemical Industries Ltd Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein
HRP980429A2 (en) 1997-08-14 1999-06-30 Jianguo Yin Crystalline 10,10-bis ((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone and an improved process for preparing the same
US20050101929A1 (en) * 2002-01-17 2005-05-12 Andrew Waksmundzki Absorbent core with three-dimensional sub-layer
MY144968A (en) * 2005-04-11 2011-11-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR053710A1 (es) * 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
AR053713A1 (es) * 2005-04-20 2007-05-16 Xenon Pharmaceuticals Inc Compuestos heterociclicos y sus usos como agentes terapeuticos
WO2008036282A1 (en) * 2006-09-18 2008-03-27 The Regents Of The University Of Californina Upregulating activity or expression of bdnf to mitigate cognitive impairment in asymptomatic huntington's subjects
EP2073806B1 (en) * 2006-10-12 2012-02-15 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
WO2008046049A1 (en) * 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
BRPI0719166A2 (pt) * 2006-10-12 2014-06-03 Xenon Pharmaceuticals Inc Derivados de espiro-oxindol tricíclicos e seus usos como agentes terapêuticos
WO2010045197A1 (en) * 2008-10-17 2010-04-22 Xenon Pharmaceuticals, Inc. Spiro-oxindole compounds and their use as therapeutic agents
HRP20150882T1 (hr) * 2008-10-17 2015-09-25 Xenon Pharmaceuticals Inc. Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
PE20170202A1 (es) 2009-10-14 2017-03-24 Xenon Pharmaceuticals Inc Metodos sinteticos para compuestos espiro-oxoindol
US20110086899A1 (en) * 2009-10-14 2011-04-14 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
RU2596488C2 (ru) 2010-02-26 2016-09-10 Ксенон Фармасьютикалз Инк. Фармацевтические композиции спиро-оксиндольного соединения для местного введения и их применение в качестве терапевтических агентов
AR103636A1 (es) 2015-02-05 2017-05-24 Teva Pharmaceuticals Int Gmbh Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol
CN106565683B (zh) * 2016-09-30 2019-03-12 江汉大学 一种合成3-羟基氧化吲哚衍生物的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314954A (en) * 1964-12-09 1967-04-18 Parke Davis & Co 1-(diloweralkylamino)-3-(aminoloweralkyl)-3-phenyloxindoles
US3595866A (en) * 1970-01-19 1971-07-27 Parke Davis & Co 1-amino-3-aminoalkyl-3-phenyloxindole-compounds
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
AU3776589A (en) * 1988-06-14 1990-01-12 Schering Corporation Heterobicyclic compounds having antiinflammatory activity
CA2037923C (en) * 1989-07-25 1996-08-06 Taiho Pharmaceutical Co., Ltd. Oxindole derivative
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US5278162A (en) * 1992-09-18 1994-01-11 The Du Pont Merck Pharmaceutical Company 3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man

Also Published As

Publication number Publication date
US5428035A (en) 1995-06-27
IL107177A0 (en) 1994-01-25
WO1994007891A1 (en) 1994-04-14
MX9306234A (es) 1994-05-31
AU5292893A (en) 1994-04-26
TW268943B (enExample) 1996-01-21
US5296478A (en) 1994-03-22

Similar Documents

Publication Publication Date Title
AU662997B2 (en) Condensed heterocyclic derivative and weedkiller
AU5292893A (en) 1-substituted oxindoles and azaoxindoles as novel cognition enhancers
AU3217897A (en) Analogs of cc-1065 and the duocarmycins
GB9204769D0 (en) Workcentre and supports
GB9208161D0 (en) Indoles
EP0572162A3 (en) Sense fet and fast amplifier
AU108633S (en) Combined tuner and amplifier
HU9502440D0 (en) Indoles as insecticides and acaricides
GB9204770D0 (en) Workcentre and supports
AU2448292A (en) Pyrimidine derivative and weedkiller
ZA93582B (en) Substituted hexahyhdroazephinones and tetrahydrobenzazepinones
EP0532288A3 (en) Composites and methods of making the same
AU3359493A (en) Determination of haptens
AU3404293A (en) Novel substituted stannosilicates and preparation thereof
AU4642793A (en) Grip enhancer
GB2274507B (en) Handlamps and torches
AU6361494A (en) Anhydroretinol and derivatives thereof as antagonists
HU9500193D0 (en) Pyridoindolo-benzo-diazepines and derivatives as antipsychotics
IL105754A0 (en) Novel pyrrolidinones
AU8110191A (en) Novel spergualin-related compound and use thereof
AU5748994A (en) Potent and specific chemically-conjugated immunotoxins
GB9212943D0 (en) Amplifier
GB2268014B (en) An amplifier
PL296873A1 (en) Substituted and heterocyclic phtalides
GB9207973D0 (en) Improvements relating to telecines and the like